For the quarter ending 2025-09-30, EOLS had -$18,215K decrease in cash & cash equivalents over the period. -$15,624K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -15,737 | -36,034 |
| Depreciation and amortization | 1,951 | 3,301 |
| Stock-based compensation | 5,135 | 10,416 |
| Provision for bad debts | 2,210 | 1,754 |
| Amortization of operating lease right-of-use assets | 330 | 572 |
| Amortization of debt discount and issuance costs | 336 | 610 |
| Deferred income taxes | -21 | 15 |
| Revaluation of contingent royalty obligation payable to evolus founders | -107 | -1,763 |
| Other adjustments to operating activities | 251 | 480 |
| Inventories | 11,492 | 4,291 |
| Accounts receivable | 4,936 | 1,781 |
| Prepaid expenses | -188 | 1,443 |
| Accounts payable | 4,112 | 3,945 |
| Accrued expenses | 2,517 | -12,835 |
| Operating lease liabilities | -290 | -256 |
| Other operating assets | -884 | 3,113 |
| Net cash used in operating activities | -14,669 | -40,423 |
| Purchases of property and equipment | 955 | 1,007 |
| Additions to capitalized software | 1,203 | 3,121 |
| Net cash used in investing activities | -2,158 | -4,128 |
| Payment of contingent royalty obligation to evolus founders | 1,786 | 4,416 |
| Proceeds from issuance and modification of debt instruments | 0 | 25,000 |
| Payments for debt modification fees and costs | 0 | 2,610 |
| Proceeds from follow-on offering | 0 | 0 |
| Payments for offering costs | 0 | 0 |
| Issuance of common stock in connection with incentive equity plan | 18 | 1,065 |
| Payment of financing lease obligation | 4 | 7 |
| Net cash provided by financing activities | -1,772 | 19,032 |
| Effect of exchange rates on cash and cash equivalents | 384 | 305 |
| Net increase (decrease) in cash and cash equivalents | -18,215 | -25,214 |
| Cash and cash equivalents at beginning of period | 86,952 | - |
| Cash and cash equivalents at end of period | 43,523 | - |
Evolus, Inc. (EOLS)
Evolus, Inc. (EOLS)